$4.88
0.12.09%
At Close: -
$4.99
0.112.25%
After Hours: 4:02 PM EDT
15 minutes delayed
Comments
Loading...
Acelyrin (NASDAQ:SLRN) Stock Quotes, Forecast and News Summary
Acelyrin Stock (NASDAQ: SLRN) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Acelyrin (SLRN) stock?
You can purchase shares of Acelyrin (NASDAQ:SLRN) through any online brokerage.
Who are Acelyrin (SLRN) competitors?
Other companies in Acelyrin’s space includes: Tectonic Therapeutic (NASDAQ:TECX), KalVista Pharma (NASDAQ:KALV), Valneva (NASDAQ:VALN), Celcuity (NASDAQ:CELC) and Larimar Therapeutics (NASDAQ:LRMR).
What is the forecast, or price target, for Acelyrin (SLRN) stock?
Acelyrin has a consensus price target of $10.83.
What is the current price for Acelyrin (SLRN)?
The stock price for Acelyrin (NASDAQ: SLRN) is $4.99 last updated September 26, 2024 at 4:02 PM EDT.
Does Acelyrin (SLRN) pay a dividend?
There are no upcoming dividends for Acelyrin.
When is Acelyrin (NASDAQ:SLRN) reporting earnings?
Acelyrin’s Q3 earnings are confirmed for Tuesday, November 5, 2024.
Is Acelyrin (SLRN) going to split?
There is no upcoming split for Acelyrin.
What sector and industry does Acelyrin (SLRN) operate in?
Acelyrin is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.